Adaptive Biotechnologies Corp. (ADPT)
24.18
-0.04
(-0.19%)
USD |
NASDAQ |
Sep 11, 16:00
24.18
0.00 (0.00%)
After-Hours: 17:09
Adaptive Biotechnologies Gross Profit (TTM) : 224.00M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 224.00M |
| March 31, 2026 | 211.63M |
| December 31, 2025 | 193.96M |
| September 30, 2025 | 169.88M |
| June 30, 2025 | 124.54M |
| March 31, 2025 | 107.81M |
| December 31, 2024 | 96.55M |
| September 30, 2024 | 90.26M |
| June 30, 2024 | 75.76M |
| March 31, 2024 | 80.03M |
| December 31, 2023 | 72.49M |
| September 30, 2023 | 85.04M |
| June 30, 2023 | 99.77M |
| March 31, 2023 | 99.65M |
| December 31, 2022 | 106.48M |
| September 30, 2022 | 91.88M |
| Date | Value |
|---|---|
| June 30, 2022 | 85.66M |
| March 31, 2022 | 85.25M |
| December 31, 2021 | 90.66M |
| September 30, 2021 | 93.55M |
| June 30, 2021 | 90.33M |
| March 31, 2021 | 78.92M |
| December 31, 2020 | 66.65M |
| September 30, 2020 | 61.22M |
| June 30, 2020 | 61.81M |
| March 31, 2020 | 63.44M |
| December 31, 2019 | 56.46M |
| September 30, 2019 | 45.93M |
| June 30, 2019 | 32.11M |
| March 31, 2019 | 17.06M |
| June 30, 2018 | 10.53M |
| March 31, 2018 | 4.873M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Personalis, Inc. | 8.838M |
| 10X Genomics, Inc. | 435.44M |
| Alamar Biosciences, Inc. (California) | 47.14M |
| Champions Oncology, Inc. | 28.93M |
| Medpace Holdings, Inc. | 772.42M |